应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RGLS Regulus Therapeutics Inc
停牌 07-09 16:49:07 EDT
8.16
+0.00
0.00%
最高
8.16
最低
8.16
成交量
0.00
今开
8.16
昨收
8.16
日振幅
0.00%
总市值
5.65亿
流通市值
4.32亿
总股本
6,923万
成交额
7,590万
换手率
0.00%
流通股本
5,294万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Regulus Therapeutics Inc.5月21日成交额为564.52万美元
市场透视 · 05-22
Regulus Therapeutics Inc.5月21日成交额为564.52万美元
Regulus Therapeutics Inc.5月20日成交额为548.52万美元
市场透视 · 05-21
Regulus Therapeutics Inc.5月20日成交额为548.52万美元
Regulus Therapeutics Inc.5月19日成交额为810.05万美元
市场透视 · 05-20
Regulus Therapeutics Inc.5月19日成交额为810.05万美元
Regulus Therapeutics Inc.2025财年第一财季实现净利润-9.63百万美元,同比减少13.70%
市场透视 · 05-17
Regulus Therapeutics Inc.2025财年第一财季实现净利润-9.63百万美元,同比减少13.70%
Regulus Therapeutics Inc.5月15日成交额为603.85万美元
市场透视 · 05-16
Regulus Therapeutics Inc.5月15日成交额为603.85万美元
Regulus Therapeutics Inc.5月14日成交额为826.53万美元
市场透视 · 05-15
Regulus Therapeutics Inc.5月14日成交额为826.53万美元
Regulus Therapeutics Inc.5月13日成交额为1116.22万美元
市场透视 · 05-14
Regulus Therapeutics Inc.5月13日成交额为1116.22万美元
Regulus Therapeutics Inc.5月8日成交额为546.34万美元
市场透视 · 05-09
Regulus Therapeutics Inc.5月8日成交额为546.34万美元
Regulus Therapeutics(RGLS.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.15美元,前值为-0.29美元,预期值为-0.23美元。
金融界 · 05-08
Regulus Therapeutics(RGLS.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.15美元,前值为-0.29美元,预期值为-0.23美元。
Regulus Therapeutics Inc.5月7日成交额为764.07万美元
市场透视 · 05-08
Regulus Therapeutics Inc.5月7日成交额为764.07万美元
Regulus Therapeutics Inc.5月6日成交额为742.06万美元
市场透视 · 05-07
Regulus Therapeutics Inc.5月6日成交额为742.06万美元
Regulus Therapeutics Inc.5月2日成交额为2402.04万美元
市场透视 · 05-03
Regulus Therapeutics Inc.5月2日成交额为2402.04万美元
Jones Trading:下调Regulus Therapeutics评级,由买入调整至持有评级, 目标价由8.00美元调整至7.00美元。
金融界 · 04-30
Jones Trading:下调Regulus Therapeutics评级,由买入调整至持有评级, 目标价由8.00美元调整至7.00美元。
加拿大投资银行集团:下调Regulus Therapeutics(RGLS.US)评级,由买入调整至持有评级, 目标价由28.00美元调整至11.00美元。
金融界 · 04-30
加拿大投资银行集团:下调Regulus Therapeutics(RGLS.US)评级,由买入调整至持有评级, 目标价由28.00美元调整至11.00美元。
Regulus Therapeutics暴涨,诺华拟斥资至多17亿美元收购该公司
老虎资讯综合 · 04-30
Regulus Therapeutics暴涨,诺华拟斥资至多17亿美元收购该公司
Regulus Therapeutics Inc.盘中异动 早盘大幅下挫5.01%报3.32美元
市场透视 · 04-29
Regulus Therapeutics Inc.盘中异动 早盘大幅下挫5.01%报3.32美元
Regulus Therapeutics Inc.盘中异动 快速拉升7.84%
市场透视 · 04-24
Regulus Therapeutics Inc.盘中异动 快速拉升7.84%
Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.84%报2.46美元
市场透视 · 04-23
Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.84%报2.46美元
Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.42%
市场透视 · 04-22
Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.42%
Regulus Therapeutics Inc.盘中异动 早盘急速上涨5.23%
市场透视 · 04-15
Regulus Therapeutics Inc.盘中异动 早盘急速上涨5.23%
加载更多
公司概况
公司名称:
Regulus Therapeutics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Regulus Therapeutics Inc.于2007年9月6日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,致力于发现和开发针对microRNA的一流药物,以治疗具有重大医疗需求的疾病。
发行价格:
--
{"stockData":{"symbol":"RGLS","market":"US","secType":"STK","nameCN":"Regulus Therapeutics Inc","latestPrice":8.16,"timestamp":1750795200000,"preClose":8.16,"halted":3,"volume":0,"delay":0,"floatShares":52938400,"shares":69234089,"eps":-0.7233,"marketStatus":"停牌","change":0,"latestTime":"07-09 16:49:07 EDT","open":8.16,"high":8.16,"low":8.16,"amount":75898393.552192,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.7233,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752105600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1349323200000,"exchange":"NASDAQ","adjPreClose":8.16,"volumeRatio":0},"requestUrl":"/m/hq/s/RGLS","defaultTab":"news","newsList":[{"id":"2537396080","title":"Regulus Therapeutics Inc.5月21日成交额为564.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537396080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537396080?lang=zh_cn&edition=full","pubTime":"2025-05-22 11:41","pubTimestamp":1747885285,"startTime":"0","endTime":"0","summary":"美东时间2025年5月21日,Regulus Therapeutics Inc.成交额为564.52万美元,成交额较昨日增加2.92%,当日成交量为71.23万股。Regulus Therapeutics Inc.于2025年5月21日跌0.38%,报7.92美元,该股过去5个交易日涨1.02%,年初至今涨401.27%,过去60日涨523.62%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-21|564.52万|2.92%|71.23万|#|2025-05-20|548.52万|-32.29%|69.44万|#|2025-05-19|810.05万|19.87%|103.09万|#|2025-05-16|675.80万|11.91%|86.00万|#|2025-05-15|603.85万|-26.94%|76.95万|Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症,代谢性疾病,纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522114126a6e83fcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522114126a6e83fcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2537748486","title":"Regulus Therapeutics Inc.5月20日成交额为548.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537748486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537748486?lang=zh_cn&edition=full","pubTime":"2025-05-21 11:32","pubTimestamp":1747798361,"startTime":"0","endTime":"0","summary":"美东时间2025年5月20日,Regulus Therapeutics Inc.成交额为548.52万美元,成交额较昨日减少32.29%,当日成交量为69.44万股。Regulus Therapeutics Inc.于2025年5月20日涨1.02%,报7.95美元,该股过去5个交易日涨1.4%,年初至今涨403.16%,过去60日涨516.28%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-20|548.52万|-32.29%|69.44万|#|2025-05-19|810.05万|19.87%|103.09万|#|2025-05-16|675.80万|11.91%|86.00万|#|2025-05-15|603.85万|-26.94%|76.95万|#|2025-05-14|826.53万|-25.95%|105.29万|Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症,代谢性疾病,纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521113243a48628e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521113243a48628e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RGLS","BK4007","LENZ"],"gpt_icon":0},{"id":"2536653476","title":"Regulus Therapeutics Inc.5月19日成交额为810.05万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536653476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536653476?lang=zh_cn&edition=full","pubTime":"2025-05-20 11:21","pubTimestamp":1747711307,"startTime":"0","endTime":"0","summary":"美东时间2025年5月19日,Regulus Therapeutics Inc.成交额为810.05万美元,成交额较昨日增加19.87%,当日成交量为103.09万股。Regulus Therapeutics Inc.于2025年5月19日涨0.0%,报7.87美元,该股过去5个交易日涨0.0%,年初至今涨398.1%,过去60日涨500.76%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-19|810.05万|19.87%|103.09万|#|2025-05-16|675.80万|11.91%|86.00万|#|2025-05-15|603.85万|-26.94%|76.95万|#|2025-05-14|826.53万|-25.95%|105.29万|#|2025-05-13|1116.22万|39.96%|141.98万|Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症,代谢性疾病,纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520112149a484d12c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520112149a484d12c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2536584766","title":"Regulus Therapeutics Inc.2025财年第一财季实现净利润-9.63百万美元,同比减少13.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536584766","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536584766?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497658,"startTime":"0","endTime":"0","summary":"5月18日,Regulus Therapeutics Inc.公布财报,公告显示公司2025财年第一财季净利润为-9.63百万美元,同比减少13.70%;其中营业收入为0.00美元,每股基本收益为-0.15美元。从资产负债表来看,Regulus Therapeutics Inc.总负债5.80百万美元,其中短期债务585000.00美元,资产负债比为12.91,流动比率为15.51。机构评级:截至2025年5月18日,当前有5家机构对Regulus Therapeutics Inc.目标价做出预测,其中目标均价为8.80美元,其中最低目标价为7.00美元,最高目标价为11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000553a4821f26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000553a4821f26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS"],"gpt_icon":0},{"id":"2535333344","title":"Regulus Therapeutics Inc.5月15日成交额为603.85万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535333344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535333344?lang=zh_cn&edition=full","pubTime":"2025-05-16 11:20","pubTimestamp":1747365607,"startTime":"0","endTime":"0","summary":"美东时间2025年5月15日,Regulus Therapeutics Inc.成交额为603.85万美元,成交额较昨日减少26.94%,当日成交量为76.95万股。Regulus Therapeutics Inc.于2025年5月15日涨0.13%,报7.85美元,该股过去5个交易日涨0.0%,年初至今涨396.84%,过去60日涨503.85%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-15|603.85万|-26.94%|76.95万|#|2025-05-14|826.53万|-25.95%|105.29万|#|2025-05-13|1116.22万|39.96%|141.98万|#|2025-05-12|797.54万|-38.35%|101.49万|#|2025-05-09|1293.71万|136.79%|164.56万|Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症,代谢性疾病,纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516112013a48059ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516112013a48059ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2535859329","title":"Regulus Therapeutics Inc.5月14日成交额为826.53万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535859329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535859329?lang=zh_cn&edition=full","pubTime":"2025-05-15 11:12","pubTimestamp":1747278740,"startTime":"0","endTime":"0","summary":"美东时间2025年5月14日,Regulus Therapeutics Inc.成交额为826.53万美元,成交额较昨日减少25.95%,当日成交量为105.29万股。Regulus Therapeutics Inc.于2025年5月14日涨0.0%,报7.84美元,该股过去5个交易日跌0.13%,年初至今涨396.2%,过去60日涨522.22%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-14|826.53万|-25.95%|105.29万|#|2025-05-13|1116.22万|39.96%|141.98万|#|2025-05-12|797.54万|-38.35%|101.49万|#|2025-05-09|1293.71万|136.79%|164.56万|#|2025-05-08|546.34万|-28.50%|69.63万|Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症,代谢性疾病,纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515111221a6dfc2fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515111221a6dfc2fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","BK4007","RGLS"],"gpt_icon":0},{"id":"2535063688","title":"Regulus Therapeutics Inc.5月13日成交额为1116.22万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535063688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535063688?lang=zh_cn&edition=full","pubTime":"2025-05-14 11:10","pubTimestamp":1747192258,"startTime":"0","endTime":"0","summary":"美东时间2025年5月13日,Regulus Therapeutics Inc.成交额为1116.22万美元,成交额较昨日增加39.96%,当日成交量为141.98万股。Regulus Therapeutics Inc.于2025年5月13日跌0.38%,报7.84美元,该股过去5个交易日涨0.13%,年初至今涨396.2%,过去60日涨547.93%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-13|1116.22万|39.96%|141.98万|#|2025-05-12|797.54万|-38.35%|101.49万|#|2025-05-09|1293.71万|136.79%|164.56万|#|2025-05-08|546.34万|-28.50%|69.63万|#|2025-05-07|764.07万|2.96%|97.38万|Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症,代谢性疾病,纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514111106a47d8a3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514111106a47d8a3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RGLS","BK4007","BK4539"],"gpt_icon":0},{"id":"2534144151","title":"Regulus Therapeutics Inc.5月8日成交额为546.34万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534144151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534144151?lang=zh_cn&edition=full","pubTime":"2025-05-09 10:39","pubTimestamp":1746758352,"startTime":"0","endTime":"0","summary":"美东时间2025年5月8日,Regulus Therapeutics Inc.成交额为546.34万美元,成交额较昨日减少28.50%,当日成交量为69.63万股。Regulus Therapeutics Inc.于2025年5月8日涨0.0%,报7.85美元,该股过去5个交易日涨0.0%,年初至今涨396.84%,过去60日涨594.69%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-08|546.34万|-28.50%|69.63万|#|2025-05-07|764.07万|2.96%|97.38万|#|2025-05-06|742.06万|-33.14%|94.61万|#|2025-05-05|1109.85万|-53.80%|141.50万|#|2025-05-02|2402.04万|-46.06%|307.49万|Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症,代谢性疾病,纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509103915a477858e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509103915a477858e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2534167413","title":"Regulus Therapeutics(RGLS.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.15美元,前值为-0.29美元,预期值为-0.23美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534167413","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534167413?lang=zh_cn&edition=full","pubTime":"2025-05-09 05:07","pubTimestamp":1746738459,"startTime":"0","endTime":"0","summary":"Regulus Therapeutics(RGLS.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.15美元,前值为-0.29美元,预期值为-0.23美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09050750243096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","RGLS"],"gpt_icon":0},{"id":"2533912058","title":"Regulus Therapeutics Inc.5月7日成交额为764.07万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533912058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533912058?lang=zh_cn&edition=full","pubTime":"2025-05-08 10:33","pubTimestamp":1746671590,"startTime":"0","endTime":"0","summary":"美东时间2025年5月7日,Regulus Therapeutics Inc.成交额为764.07万美元,成交额较昨日增加2.96%,当日成交量为97.38万股。Regulus Therapeutics Inc.于2025年5月7日涨0.26%,报7.85美元,该股过去5个交易日跌1.63%,年初至今涨396.84%,过去60日涨554.17%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-07|764.07万|2.96%|97.38万|#|2025-05-06|742.06万|-33.14%|94.61万|#|2025-05-05|1109.85万|-53.80%|141.50万|#|2025-05-02|2402.04万|-46.06%|307.49万|#|2025-05-01|4453.28万|-80.15%|567.41万|Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症,代谢性疾病,纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508103315a6d709ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508103315a6d709ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2533648631","title":"Regulus Therapeutics Inc.5月6日成交额为742.06万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533648631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533648631?lang=zh_cn&edition=full","pubTime":"2025-05-07 10:32","pubTimestamp":1746585168,"startTime":"0","endTime":"0","summary":"美东时间2025年5月6日,Regulus Therapeutics Inc.成交额为742.06万美元,成交额较昨日减少33.14%,当日成交量为94.61万股。Regulus Therapeutics Inc.于2025年5月6日跌0.25%,报7.83美元,该股过去5个交易日涨132.34%,年初至今涨395.57%,过去60日涨557.98%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-06|742.06万|-33.14%|94.61万|#|2025-05-05|1109.85万|-53.80%|141.50万|#|2025-05-02|2402.04万|-46.06%|307.49万|#|2025-05-01|4453.28万|-80.15%|567.41万|#|2025-04-30|2.24亿|2930.72%|2856.67万|Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症,代谢性疾病,纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507103253a6d5bf1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507103253a6d5bf1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","RGLS"],"gpt_icon":0},{"id":"2532802725","title":"Regulus Therapeutics Inc.5月2日成交额为2402.04万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532802725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532802725?lang=zh_cn&edition=full","pubTime":"2025-05-03 10:29","pubTimestamp":1746239370,"startTime":"0","endTime":"0","summary":"美东时间2025年5月2日,Regulus Therapeutics Inc.成交额为2402.04万美元,成交额较昨日减少46.06%,当日成交量为307.49万股。Regulus Therapeutics Inc.于2025年5月2日涨0.0%,报7.85美元,该股过去5个交易日涨184.42%,年初至今涨396.84%,过去60日涨494.7%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-02|2402.04万|-46.06%|307.49万|#|2025-05-01|4453.28万|-80.15%|567.41万|#|2025-04-30|2.24亿|2930.72%|2856.67万|#|2025-04-29|740.30万|-54.06%|220.18万|#|2025-04-28|1611.44万|553.80%|477.42万|Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症,代谢性疾病,纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503102932a6d1a27f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503102932a6d1a27f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","RGLS","BK4139"],"gpt_icon":0},{"id":"2532061934","title":"Jones Trading:下调Regulus Therapeutics评级,由买入调整至持有评级, 目标价由8.00美元调整至7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532061934","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532061934?lang=zh_cn&edition=full","pubTime":"2025-05-01 01:51","pubTimestamp":1746035517,"startTime":"0","endTime":"0","summary":"Jones Trading:下调Regulus Therapeutics(RGLS.US)评级,由买入调整至持有评级, 目标价由8.00美元调整至7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050101552794e93759&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050101552794e93759&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ"],"gpt_icon":0},{"id":"2532061248","title":"加拿大投资银行集团:下调Regulus Therapeutics(RGLS.US)评级,由买入调整至持有评级, 目标价由28.00美元调整至11.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532061248","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532061248?lang=zh_cn&edition=full","pubTime":"2025-05-01 01:51","pubTimestamp":1746035517,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团:下调Regulus Therapeutics(RGLS.US)评级,由买入调整至持有评级, 目标价由28.00美元调整至11.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/01015150064298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","RGLS"],"gpt_icon":0},{"id":"1138474240","title":"Regulus Therapeutics暴涨,诺华拟斥资至多17亿美元收购该公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1138474240","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138474240?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:45","pubTimestamp":1746020757,"startTime":"0","endTime":"0","summary":"该交易预计将于今年下半年完成。","market":"us","thumbnail":"https://static.tigerbbs.com/1766d484cdc0ac264f4ce34be3fa9fc2","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1766d484cdc0ac264f4ce34be3fa9fc2"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGLS"],"gpt_icon":0},{"id":"2531757873","title":"Regulus Therapeutics Inc.盘中异动 早盘大幅下挫5.01%报3.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531757873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531757873?lang=zh_cn&edition=full","pubTime":"2025-04-29 23:12","pubTimestamp":1745939537,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日23时12分,Regulus Therapeutics Inc.股票出现波动,股价大幅下跌5.01%。截至发稿,该股报3.32美元/股,成交量85.2455万股,换手率1.29%,振幅7.94%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.43%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429231217a6cd8378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429231217a6cd8378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2529931616","title":"Regulus Therapeutics Inc.盘中异动 快速拉升7.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529931616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529931616?lang=zh_cn&edition=full","pubTime":"2025-04-24 21:30","pubTimestamp":1745501446,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日21时30分,Regulus Therapeutics Inc.股票出现异动,股价急速上涨7.84%。截至发稿,该股报2.75美元/股,成交量8.3019万股,换手率0.13%,振幅5.88%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504242130469743a712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504242130469743a712&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2529668146","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.84%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529668146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529668146?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:30","pubTimestamp":1745415028,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时30分,Regulus Therapeutics Inc.股票出现异动,股价大幅拉升5.84%。截至发稿,该股报2.46美元/股,成交量4.5593万股,换手率0.07%,振幅1.09%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Ensysce Biosciences, Inc.、Rezolute, Inc.、Glycomimetics, Inc.涨幅较大,Ensysce Biosciences, Inc.、Onconetix, Inc.、Ocean Biomedical, Inc.较为活跃,换手率分别为2736.19%、17.21%、6.61%,振幅较大的相关个股有Biohaven Ltd.、Candel Therapeutics, Inc.、Igc Pharma, Inc.,振幅分别为6.38%、5.60%、4.90%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321302897423191&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321302897423191&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2529846587","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529846587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529846587?lang=zh_cn&edition=full","pubTime":"2025-04-22 22:18","pubTimestamp":1745331529,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日22时18分,Regulus Therapeutics Inc.股票出现异动,股价急速上涨5.42%。截至发稿,该股报2.12美元/股,成交量10.9651万股,换手率0.17%,振幅5.22%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.38%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422221849a46294be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422221849a46294be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS","BK4007"],"gpt_icon":0},{"id":"2527941773","title":"Regulus Therapeutics Inc.盘中异动 早盘急速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527941773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527941773?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:39","pubTimestamp":1744724359,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时39分,Regulus Therapeutics Inc.股票出现波动,股价大幅拉升5.23%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,Mural Oncology Plc、Verve Therapeutics, Inc.、Precision Biosciences, Inc.涨幅较大,Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃,换手率分别为461.65%、208.81%、82.51%,振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc、Nextcure, Inc.,振幅分别为80.08%、52.43%、38.78%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041521391994d62cd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041521391994d62cd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","RGLS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regulusrx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0073},{"period":"3month","weight":3.7719},{"period":"6month","weight":4.4765},{"period":"1year","weight":3.6364},{"period":"ytd","weight":4.1646}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Regulus Therapeutics Inc.于2007年9月6日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,致力于发现和开发针对microRNA的一流药物,以治疗具有重大医疗需求的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":-0.043674},{"month":2,"riseRate":0.384615,"avgChangeRate":0.02347},{"month":3,"riseRate":0.538462,"avgChangeRate":0.105895},{"month":4,"riseRate":0.307692,"avgChangeRate":0.22053},{"month":5,"riseRate":0.538462,"avgChangeRate":0.07742},{"month":6,"riseRate":0.384615,"avgChangeRate":-0.107927},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.130856},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.042258},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.004778},{"month":10,"riseRate":0.166667,"avgChangeRate":0.026008},{"month":11,"riseRate":0.461538,"avgChangeRate":0.057414},{"month":12,"riseRate":0.384615,"avgChangeRate":0.049982}],"exchange":"NASDAQ","name":"Regulus Therapeutics Inc","nameEN":"Regulus Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Regulus Therapeutics Inc,RGLS,Regulus Therapeutics Inc股票,Regulus Therapeutics Inc股票老虎,Regulus Therapeutics Inc股票老虎国际,Regulus Therapeutics Inc行情,Regulus Therapeutics Inc股票行情,Regulus Therapeutics Inc股价,Regulus Therapeutics Inc股市,Regulus Therapeutics Inc股票价格,Regulus Therapeutics Inc股票交易,Regulus Therapeutics Inc股票购买,Regulus Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}